Frontiers in nephrology: Immune tolerance to allografts in humans

Journal of the American Society of Nephrology

Volumn 18, Issue 8, 2007, Pages 2242-2251

  Girlanda, Raffaele ^a   Kirk, Allan D ^a,b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b Building 10CRC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; STEROID;

ALLOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CHIMERA; DISEASE MODEL; GRAFT SURVIVAL; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; NEPHROLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REPEATED DRUG DOSE; REVIEW; T CELL DEPLETION; TRANSPLANTATION TOLERANCE;

EID: 34547641365     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2007020180     Document Type: Review

References (130)

1. Gaspare Tagliacozzi (1545-1599): Surgical Implants for Mutilations, edited by Gaspace Bindoni the Younger, Venice, 1597
2. Padgett ECM: Is iso-skin grafting practicable? South Med J 25: 895-900, 1932
3. Brown JB: Homografting of skin: With report of success in identical twins. Surgery 1: 558-563, 1937
4. Billingham RE, Brent L, Medawar PB: "Actively acquired" tolerance of foreign cells. Nature 172: 603-606, 1953
5. Calne RY, Sells RA, Pena JR, Davis DR, Millard PR, Herbertson BM, Binns RM, Davies DA: Induction of immunological tolerance by porcine liver allografts. Lancet 223: 472-476, 1969
6. Horner BM, Cina RA, Wikiel KJ, Lima B, Ghazi A, Lo DP, Yamada K, Sachs DH, Huang CA: Predictors of organ allograft tolerance following hematopoietic cell transplantation. Am J Transplant 6: 2894-2902, 2006
7. Kuhr CS, Allen MD, Junghanss C, Zaucha JM, Marsh CL, Yunusov M, Zellme E, Little MT, Torok-Storb B, Storb R: Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras. Transplantation 73: 1487-1493, 2002
8. Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, Kiem HP, Leisenring W, Shulman H: Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89: 3048-3054, 1997
9. Strober S, Modry DL, Hoppe RT, Pennock JL, Bieber CP, Holm BI, Jamieson SW, Stinson EB, Schroder J, Suomalainen H: Induction of specific unresponsiveness to heart allografts in mongrel dogs treated with total lymphoid irradiation and antithymocyte globulin. J Immunol 132: 1013-1018, 1984
10. Kean LS, Gangappa S, Pearson TC, Larsen CP: Transplant tolerance in non-human primates: Progress, current challenges and unmet needs. Am J Transplant 6: 884-893, 2006
11. Kirk AD: Crossing the bridge: Large animal models in translational transplantation research. Immunol Rev 196: 176-196, 2003
12. Williams A, Eldridge R, McFarland H, Houff S, Krebs H, McFarlin D: Multiple sclerosis in twins. Neurology 30: 1139-1147, 1980
13. Brandrup F, Holm N, Grunnet N, Henningsen K, Hansen HE: Psoriasis in monozygotic twins: Variations in expression in individuals with identical genetic constitution. Acta Derm Venereol 62: 229-236, 1982
14. Adams AB, Williams MA, Jones TR, Shirasugi N, Durham MM, Kaech SM, Wherry EJ, Onami T, Lanier JG, Kokko KE, Pearson TC, Ahmed R, Larsen CP: Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 111: 1887-1895, 2003
15. Roussey-Kesler G, Giral M, Moreau A, Subra JF, Legendre C, Noel C, Pillebout E, Brouard S, Soulillou JP: Clinical operational tolerance after kidney transplantation. Am J Transplant 6: 736-746, 2006
16. Newell KA, Burlingham WJ, Marks VH, Gisler TD, Seyfert VL, Ding R, Turka LA, Suthanthiran M, Kirk AD: Preliminary analysis of the ITN registry of tolerant kidney transplant recipients. Transplantation 82: 1055, 2006
17. United Network for Organ Sharing: Data, Richmond, VA, United Network for Organ Sharing. Available at: www.unos.org/data. Accessed December 14, 2006
18. Lerut J, Sanchez-Fueyo A: An appraisal of tolerance in liver transplantation. Am J Transplant 6: 1774-1780, 2006
19. Donohoe JA, Andrus L, Bowen KM, Simeonovic C, Prowse SJ, Lafferty KJ: Cultured thyroid allografts induce a state of partial tolerance in adult recipient mice. Transplantation 35: 62-67, 1983
20. Crispe IN, Giannandrea M, Klein I, John B, Sampson B, Wuensch S: Cellular and molecular mechanisms of liver tolerance. Immunol Rev 213: 101-118, 2006
21. Asolati M, Testa G, Gangemi A, Sankary H, Oberholzer J, Benedetti E: 'Prope' tolerance in a noncompliant living related small bowel transplant recipient after severe rejection. Transplantation 83: 77-79, 2007
22. Zoller KM: Cessation of immunosuppressive therapy after successful transplantation: A national survey. Kidney Int 18: 110-114, 1980
23. Li Y, Koshiba T, Yoshizawa A, Yonekawa Y, Masuda K, Ito A, Ueda M, Mori T, Kawamoto H, Tanaka Y, Sakaguchi S, Minato N, Wood KJ, Tanaka K: Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 4: 2118-2125, 2004
24. Martinez-Llordella M, Puig-Pey I, Orlando G, Ramoni M, Tisone G, Rimola A, Lerut J, Latinne D, Margarit C, Bilbao I, Brouard S, Hernandez-Fuentes M, Soulillou J-P, Sanchez-Fueyo A: Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 7: 309-319, 2007
25. Mazariegos GV, Zahorchak AF, Reyes J, Ostrowski L, Flynn B, Zeevi A, Thomson AW: Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant 3: 689-696, 2003
26. Kirk AD: Meteorology and tolerance. Am J Transplant 6: 645-646, 2006
27. Selin LK, Brehm MA, Naumov YN, Cornberg M, Kim SK, Clute SC, Welsh RM: Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity. Immunol Rev 211: 164-181, 2006
28. Tan HP, Kaczorowski DJ, Basu A, Unruh M, McCauley J, Wu C, Donaldson J, Dvorchik I, Kayler L, Marcos A, Randhawa P, Smetanka C, Starzl TE, Shapiro R: Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant 6: 2409-2417, 2006
29. Strober S: Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation. N Engl J Med 321: 28-33, 1989
30. Girlanda R, Rela M, Williams R, O'Grady JG, Heaton ND: Long-term outcome of immunosuppression withdrawal after liver transplantation. Transplant Proc 37: 1708-1709, 2005
31. Myburgh JA, Smit JA, Hill RR, Browde S: Transplantation tolerance in primates following total lymphoid irradiation and allogeneic bone marrow injection. II. Renal allografts. Transplantation 29: 405-408, 1980
32. Kawai T, Cosimi AB, Colvin RB, Powelson J, Eason J, Kozlowski T, Sykes M, Monroy R, Tanaka M, Sachs DH: Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 59: 256-262, 1995
33. Gudmundsdottir H, Turka LA: T cell costimulatory blockade: New therapies for transplant rejection. J Am Soc Nephrol 10: 1356-1365, 1999
34. Dong VM, Womer KL, Sayegh MH: Transplantation tolerance: The concept and its applicability. Pediatr Transplant 3: 181-192, 1999
35. Thomas W, Megan S: Induction of tolerance. Surgery 135: 359-364, 2004
36. Kirk AD: Ethics in the quest for transplant tolerance. Transplantation 77: 947-951, 2004
37. Kirk AD: Induction immunosuppression. Transplantation 82: 593-602, 2006
38. Sykes M: Mixed chimerism and transplant tolerance. Immunity 14: 417-424, 2001
39. Roy Calne S: Progress toward tolerance and xenografting. Transplant Proc 29: 16-18, 1997
40. Starzl TE, Marchioro TL, Wadell WR: The reversal of rejection in human renal homografts with subsequent development of homograft tolerance. Surg Gynecol Obstet 117: 385-395, 1963
41. Starzl TE, Murase N, Demetris AJ, Trucco M, Abu-Elmagd K, Gray EA, Eghtesad B, Shapiro R, Marcos A, Fung JJ: Lessons of organ-induced tolerance learned from historical clinical experience. Transplantation 77: 926-929, 2004
42. Karim M, Steger U, Bushell AR, Wood KJ: The role of the graft in establishing tolerance. Front Biosci 7: e129-e154, 2002
43. Green DR, Droin N, Pinkoski M: Activation-induced cell death in T cells. Immunol Rev 193: 70-81, 2003
44. Li Y, Li XC, Zheng XX, Wells AD, Turka LA, Strom TB: Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 5: 1298-1302, 1999
45. Wells AD, Li XC, Li Y, Walsh MC, Zheng XX, Wu Z, Nunez G, Tang A, Sayegh M, Hancock WW, Strom TB, Turka LA: Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 5: 1303-1307, 1999
46. Adams AB, Shirasugi N, Jones TR, Williams MA, Durham MM, Ha J, Dong Y, Guo Z, Newell KA, Pearson TC, Larsen CP: Conventional immunosuppression is compatible with costimulation blockade-based, mixed chimerism tolerance induction. Am J Transplant 3: 895-901, 2003
47. Blaha P, Bigenzahn S, Koporc Z, Schmid M, Langer F, Selzer E, Bergmeister H, Wrba F, Kurtz J, Kiss C, Roth E, Muehlbacher F, Sykes M, Wekerle T: The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 101: 2886-2893, 2003
48. Opelz G: Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 5: 253-259, 1973
49. Flye MW: Donor-specific transfusions have long-term beneficial effects for human renal allografts. Transplantation 60: 1395-1401, 1995
50. Monaco AP: Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: Case report of an initial attempt. Surgery 79: 384-392, 1976
51. Barber WH: Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 51: 70-75, 1991
52. Ciancio G, Burke GW, Moon J, Garcia-Morales R, Rosen A, Esquenazi V, Mathew J, Jin Y, Miller J: Donor bone marrow infusion in deceased and living donor renal transplantation. Yonsei Med J 45: 998-1003, 2004
53. Wood KJ, Jones ND, Bushell AR, Morris PJ: Alloantigen-induced specific immunological unresponsiveness. Phil Trans R Soc B 356: 665-680, 2001
54. Swanson SJ, Hale DA, Mannon RB, Kleiner DE, Cendales LC, Chamberlain CE, Polly SM, Harlan DM, Kirk AD: Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy. Lancet 360: 1662-1664, 2002
55. Starzl TE, Murase N, Abu-Elmagd K, Gray EA, Shapiro R, Eghtesad B, Corry RJ, Jordan ML, Fontes P, Gayowski T: Tolerogenic immunosuppression for organ transplantation. Lancet 361: 1502-1510, 2003
56. Starzl TE: Chimerism and tolerance in transplantation. Proc Natl Acad Sci U S A 101: 14607-14614, 2004
57. Starzl TE, Murase N, Ildstad S, Ricordi C, Demetris AJ, Trucco M: Cell migration, chimerism, and graft acceptance. Lancet 339: 1579-1582, 1992
58. Ciancio G, Miller J, Garcia-Morales RO, Carreno M, Burke GWI, Roth D, Kupin W, Tzakis AG, Ricordi C, Rosen A, Fuller L, Esquenazi V: Six-year clinical effect of donor bone marrow infusions in renal transplant patients. Transplantation 71: 827-835, 2001
59. Wekerle T, Sykes M: Mixed chimerism and transplantation tolerance. Annu Rev Med 52: 353-370, 2001
60. Monaco AP, Medawar P: Chimerism in organ transplantation: Conflicting experiments and clinical observations. Transplantation 75: 13S-16S, 2003
61. Sayegh MH: Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med 114: 954-955, 1991
62. Helg C: Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation. Transplantation 58: 1420-1422, 1994
63. Sorof JM: Renal transplantation without chronic immunosuppression after T cell-depleted, HLA-mismatched bone marrow transplantation. Transplantation 59: 1633-1635, 1995
64. Butcher JA, Hariharan S, Adams MB, Johnson CP, Roza AM, Cohen EP: Renal transplantation for end-stage renal disease following bone marrow transplantation: A report of six cases, with and without immunosuppression. Clin Transplant 13: 330-335, 1999
65. Dey BM, Sykes MM, Spitzer TRM: Outcomes of recipients of both bone marrow and solid organ transplants: A review. Medicine 77: 355-369, 1998
66. Jacobsen N, Taaning E, Ladefoged J, Kvist Kristensen J, Pedersen F: Tolerance to an HLA-B, DR disparate kidney allograft after bone-marrow transplantation from same donor. Lancet 343: 800, 1994
67. Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Sachs DH: Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J Exp Med 162: 231-244, 1985
68. Sykes M, Szot GL, Swenson KA, Pearson DA: Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat Med 3: 783-787, 1997
69. Domenig C, Sanchez-Fueyo A, Kurtz J, Alexopoulos SP, Mariat C, Sykes M, Strom TB, Zheng XX: Roles of deletion and regulation in creating mixed chimerism and allograft tolerance using a nonlymphoablative irradiation-free protocol. J Immunol 175: 51-60, 2005
70. Spitzer TR, Delmonico F, Tolkoff-Rubin N, McAfee S, Sackstein R, Saidman S, Colby C, Sykes M, Sachs DH, Cosimi AB: Combined histocompatibility leukocyte antigen matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 68: 480-484, 1999
71. Millan MT, Shizuru JA, Hoffmann P, Dejbakhsh-Jones S, Scandling JD, Carl Grumet F, Tan JC, Salvatierra O, Hoppe RT, Strober S: Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 72: 1386-1391, 2002
72. Sykes M, Shimizu I, Kawahara T: Mixed hematopoietic chimerism for the simultaneous induction of T and B cell tolerance. Transplantation 79[Suppl]: S28-S29, 2005
73. Buhler LH, Spitzer TR, Sykes M, Sachs DH, Delmonico FL, Tolkoff-Rubin N, Saidman SL, Sackstein R, McAfee S, Dey B, Colby C, Cosimi AB: Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation 74: 1405-1409, 2002
74. De Pauw L, Toungouz M, Goldman M: Infusion of donor-derived hematopoietic stem cells in organ transplantation: Clinical data. Transplantation 75[Suppl]: 46S-49S, 2003
75. Kawai T, Sachs DH, Spitzer T, Tolkoff-Rubin N, Shaffer J, Saidman S, Williams W, Dey B, Goes N, Ko D, Hertl M, Cotter P, Wong W, Colvin RB, Sykes M, Cosimi AB: Successful induction of renal allograft tolerance in HLA-mismatched kidney transplant recipients. Transplantation 82[Suppl 2]: 169, 2006
76. Lakkis FG, Arakelov A, Konieczny BT, Inoue Y: Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 6: 686-688, 2000
77. Raaf J, Bryan C, Monden M, Bray A, Kim JH, Chu F, Chaganti RS, Shank B, Cahan A, Fortner JG: Bone marrow and renal transplantation in canine recipients prepared by total lymphoid irradiation. Transplant Proc 13: 429-433, 1981
78. Levin B, Collins G, Waer M, Girinsky T, Hoppe R, Miller E, Bieber C, Strober S: Treatment of cadaveric renal transplant recipients with total lymphoid irradiation, antithymocyte globulin, and low-dose prednisone. Lancet 326: 1321-1325, 1985
79. Strober S, Benike C, Krishnaswamy S, Engleman EG, Grumet FC: Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: Studies of chimerism and anti-donor reactivity. Transplantation 69: 1549-1554, 2000
80. Strober S, Lowsky RJ, Shizuru JA, Scandling JD, Millan MT: Approaches to transplantation tolerance in humans. Transplantation 77: 932-936, 2004
81. Ford WL, Atkins RC: The proportion of lymphocytes capable of recognizing strong transplantation antigens in vivo. Adv Exp Med Biol 29: 255-262, 1973
82. Suchin EJ, Langmuir PB, Palmer E, Sayegh MH, Wells AD, Turka LA: Quantifying the frequency of alloreactive T cells in vivo: New answers to an old question. J Immunol 166: 973-981, 2001
83. Pearl JP, Parris J, Hale DA, Hoffmann SC, Bernstein WB, McCoy KL, Swanson SJ, Mannon RB, Roederer M, Kirk AD: Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 5: 465-474, 2005
84. Wu Z, Bensinger SJ, Zhang J, Chen C, Yuan X, Huang X, Markmann JF, Kassaee A, Rosengard BR, Hancock WW, Sayegh MH, Turka LA: Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med 10: 87-92, 2004
85. Neujahr DC, Chen C, Huang X, Markmann JF, Cobbold S, Waldmann H, Sayegh MH, Hancock WW, Turka LA: Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol 176: 4632-4639, 2006
86. Kirk AD, Hale DA, Mannon RB, Kleiner DE, Hoffmann SC, Kampen RL, Cendales LK, Tadaki DK, Harlan DM, Swanson SJ: Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 76: 120-129, 2003
87. Calne RY: Prope tolerance: The future of organ transplantation from the laboratory to the clinic. Transpl Immunol 13: 83-86, 2004
88. Larsen CP, Knechtle SJ, Adams A, Pearson T, Kirk AD: A new look at blockade of T-cell costimulation: A therapeutic strategy for long-term maintenance immunosuppression. Am J Transplant 6: 876-883, 2006
89. Alegre ML, Najafian N: Costimulatory molecules as targets for the induction of transplantation tolerance. Curr Mol Med 8: 843-857, 2006
90. Yamada A, Sayegh MH: The CD154-CD40 costimulatory pathway in transplantation. Transplantation 73[Suppl]: S36-S39, 2002
91. Harlan DM, Kirk AD: The future of organ and tissue transplantation: Can T-cell costimulatory pathway modifiers revolutionize the prevention of graft rejection? JAMA 282: 1076-1082, 1999
92. Cunningham AJ, Lafferty KJ: A simple conservative explanation of the H-2 restriction of interactions between lymphocytes. Scand J Immunol 6: 1-6, 1977
93. Kirk AD, Burkly LC, Batty DS, Baumgartner RE, Berning JD, Buchanan K, Fechner JH, Germond RL, Kampen RL, Patterson NB, Swanson SJ, Tadaki DK, TenHoor CN, White L, Knechtle SJ, Harlan DM: Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 5: 686-693, 1999
94. Kirk AD, Harlan DM, Armstrong NN, Davis TA, Dong Y, Gray GS, Hong X, Thomas D, Fechner JH Jr, Knechtle SJ: CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A 94: 8789-8794, 1997
95. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC: Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381: 434-438, 1996
96. Kirk AD, Tadaki DK, Celniker A, Scott Batty D, Berning JD, Colonna JO, Cruzata F, Elster EA, Gray GS, Kampen RL, Patterson NB, Szklut P, Swanson J, Xu H, Harlan DM: Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates. Transplantation 72: 377-384, 2001
97. Preston EH, Xu H, Dhanireddy KK, Pearl JP, Leopardi FV, Starost MF, Hale DA, Kirk AD: IDEC-131 (Anti-CD154), Sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates. Am J Transplant 5: 1032-1041, 2005
98. Kawai T, Sogawa H, Boskovic S, Abrahamian G, Smith RN, Wee SL, Andrews D, Nadazdin O, Koyama I, Sykes M, Winn HJ, Colvin RB, Sachs DH, Cosimi AB: CD154 Blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am J Transplant 4: 1391-1398, 2004
99. Kean LS, Adams AB, Strobert E, Hendrix R, Gangappa S, Jones TR, Shirasugi N, Rigby MR, Hamby K, Jiang J, Bello H, Anderson D, Cardona K, Durham MM, Pearson TC, Larsen CP: Induction of chimerism in rhesus macaques through stem cell transplant and costimulation blockade-based immunosuppression. Am J Transplant 7: 320-335, 2007
100. Salomon B, Bluestone JA: Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 19: 225-252, 2001
101. Larsen CP, Pearson TC, Adams AB, Tso P, Shirasugi N, Strobert ME, Anderson D, Cowan S, Price K, Naemura J, Emswiler J, Greene J, Turk LA, Bajorath J, Townsend R, Hagerty D, Linsley PS, Peach RJ: Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am J Transplant 5: 443-453, 2005
102. Vincenti F, Larsen C, Durrbach A, Wekerle T, Nashan B, Blancho G, Lang P, Grinyo J, Halloran PF, Solez K, Hagerty D, Levy E, Zhou W, Natarajan K, Charpentier B; the Belatacept Study Group: Costimulation blockade with belatacept in renal transplantation. N Engl J Med 353: 770-781, 2005
103. Rice HE, Skinner MA, Mahaffey SM, Oldham KT, Ing RJ, Hale LP, Markert ML: Thymic transplantation for complete DiGeorge syndrome: Medical and surgical considerations. J Pediatr Surg 39: 1607-1615, 2004
104. Posselt AM, Barker CF, Tomaszewski JE, Markmann JF, Choti MA, Naji A: Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 249: 1293-1295, 1990
105. Odorico JS: Induction of donor-specific tolerance to rat cardiac allografts by intrathymic inoculation of bone marrow. Surgery 112: 370-376, 1992
106. Knechtle SJ, Wang J, Jiao S, Geissler EK, Sumimoto R, Wolff J: Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex. Transplantation 57: 990-996, 1994
107. Ohzato H, Monaco AP: Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice. Transplantation 54: 1090-1095, 1992
108. Knechtle SJ, Wang J, Graeb C, Zhai Y, Hong X, Fechner JH Jr, Geissler EK: Direct MHC class I complementary DNA transfer to thymus induces donor-specific unresponsiveness, which involves multiple immunologic mechanisms. J Immunol 159: 152-158, 1997
109. Goss JA, Nakafusa Y Flye MW: Intrathymic injection of donor alloantigens induces donor-specific vascularized allograft tolerance without immunosuppression. Ann Surg 216: 414-416, 1992
110. Remuzzi G, Rossini M, Imberti O, Perico N: Kidney graft survival in rats without immunosuppressants after intrathymic glomerular transplantation. Lancet 337: 750-752, 1991
111. Yamada K, Shimizu A, Ierino FL, Utsugi R, Barth RN, Esnaola N, Colvin RB, Sachs DH: Thymic transplantation in miniature swine: I. Development and function of the "Thymokidney." Transplantation 68: 1684-1692, 1999
112. Johnston DR, Muniappan A, Hoerbelt R, Guenther DA, Shoji T, Houser SL, Sachs DH, Madsen JC: Heart and en-bloc thymus transplantation in miniature swine. J Thorac Cardiovasc Surg 130: 554-559, 2005
113. Nobori S, Shimizu A, Okumi M, Samelson-Jones E, Griesemer A, Hirakata A, Sachs DH, Yamada K: Thymic rejuvenation and the induction of tolerance by adult thymic grafts. Proc Natl Acad Sci U S A 103: 19081-19086, 2006
114. Newell KA, Larsen CP: Tolerance assays: Measuring the unknown. Transplantation 81: 1503-1509, 2006
115. Najafian N, Albin MJ, Newell KA: How can we measure immunologic tolerance in humans? J Am Soc Nephrol 17: 2652-2663, 2006
116. Poggio ED, Clemente M, Hricik DE, Heeger PS: Panel of reactive T cells as a measurement of primed cellular alloimmunity in kidney transplant candidates. J Am Soc Nephrol 17: 564-572, 2006
117. Najafian N, Salama AD, Fedoseyeva EV, Benichou G, Sayegh MH: Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: Potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 13: 252-259, 2002
118. Sarwal M, Chua MS, Kambham N, Hsieh SC, Satterwhite T, Masek M, Salvatierra O Jr: Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 349: 125-138, 2003
119. Hoffmann SC, Pearl JP, Blair PJ, Kirk AD: Immune profiling: Molecular monitoring in renal transplantation. Front Biosci 8: e444-e462, 2003
120. Bloom DD, Hu H, Fechner JH, Knechtle SJ: T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients. Transplantation 81: 81-87, 2006
121. Muthukumar T, Dadhania D, Ding R, Snopkowski C, Naqvi R, Lee JB, Hartono C, Li B, Sharma VK, Seshan SV, Kapur S, Hancock WW, Schwartz JE, Suthanthiran M: Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 353: 2342-2351, 2005
122. Schaub S, Rush D, Wilkins J, Gibson IW, Weiler T, Sangster K, Nicolle L, Karpinski M, Jeffery J, Nickerson P: Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 15: 219-227, 2004
123. Hu H, Aizenstein BD, Puchalski A, Burmania JA, Hamawy MM, Knechtle SJ: Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction. Am J Transplant 4: 432-437, 2004
124. Calne R, Friend P, Moffatt S, Bradley A, Hale G, Firth J, Bradley J, Smith K, Waldmann H: Prope tolerance, perioperative Campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 351: 1701-1702, 1998
125. Rotrosen D, Matthews J, Bluestone J: The immune tolerance network: A new paradigm for developing tolerance-inducing therapies. J Allergy Clin Immunol 110: 17-23, 2002
126. Owens ML: Discontinuance of immunosuppression in renal transplant patients. Arch Surg 110: 1450-1451, 1975
127. Uehling DT: Cessation of immunosuppression after renal transplantation. Surgery 79: 278-282, 1976
128. Burlingham WJ: Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation 59: 1147-1155, 1995
129. Fischer T, Schobel H, Barenbrock M: Specific immune tolerance during pregnancy after renal transplantation. Eur J Obstet Gynecol Reprod Biol 70: 217-219, 1996
130. Christensen LL: Indications of immunological tolerance in kidney transplantation. Tissue Antigens 51: 637-644, 1998